| 2013 | A prospective multicenter, single blinded, randomized phase III trial to compare the efficacy of ramosetron, aprepitant and dexamethasone with ondansetron, aprepitant, and dexamethasone for preventing chemotherapy-induced nausea and vomiting: KCSG PC10-21. | 이순남 | Meeting Abstract |
| 2020 | Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family members | 남은미 | Article |
| 2019 | Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act | 남은미 | Article |
| 2018 | Comparison of attitudes towards five end-of-life care interventions (active pain control, withdrawal of futile life-sustaining treatment, passive euthanasia, active euthanasia and physician-assisted suicide): a multicentred cross-sectional survey of Korean patients with cancer, their family caregivers, physicians and the general Korean population | 남은미 | Article |
| 2018 | Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study | 남은미 | Article |
| 2019 | Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial | 문영철 | Article |
| 2018 | Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey | 이순남 | Article |
| 2015 | Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21 | 이순남 | Article |
| 2020 | The Attitudes of Physicians and the General Public toward Prognostic Disclosure of Different Serious Illnesses: a Korean Nationwide Study | 이순남 | Article |
